Refractory Low Grade Non-Hodgkin's Lymphoma (NHL)
Drug | Drug Name | Drug Description |
---|---|---|
DB00073 | Rituximab | A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00073 | Rituximab | B-lymphocyte antigen CD20 | target |
Drug | Drug Name | Phase | Status | Count |
---|